Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
US Department of Justice
Moodys
Cantor Fitzgerald
Dow
US Army
Merck
QuintilesIMS

Generated: April 24, 2018

DrugPatentWatch Database Preview

PREMARIN Drug Profile

« Back to Dashboard

When do Premarin patents expire, and when can generic versions of Premarin launch?

Premarin is a drug marketed by Wyeth Pharms Inc and is included in three NDAs.

The generic ingredient in PREMARIN is estrogens, conjugated. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.
Drug patent expirations by year for PREMARIN
Pharmacology for PREMARIN
Ingredient-typeEstrogens, Conjugated (USP)
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Synonyms for PREMARIN
16680-47-0
17-Oxoestra-1,3,5(10),7-tetraen-3-yl sodium sulfate
27540-07-4 (Parent)
3-(Sulfooxy)estra-1,3,5(10),7-tetraen-17-one Sodium Salt
3-Hydroxyestra-1,3,5(10),7-tetraen-17-one Hydrogen Sulfate Sodium Salt
7XY8FW3E68
AKOS027322958
Ayerogen
Ayerogen Crema Vaginal
Azumon
C.E.S
C13416
CCRIS 7207
CEE
Cenestin
CHEBI:32143
Climarest
Climatrol
Climestrone
Climopax
CO-Estro
Conest
Conestron
Conjes
Conjugated equine estrogen
Conjugated estrogenic hormones
Conjugated estrogens: sodium equilin sulfate
Conjugen
Conjutabs
D02YUT
Dagynil
DTXSID00872961
EINECS 235-199-5
EINECS 240-727-2
Emopremarin
Equigyne
Equilin 3-Sulfate Sodium Salt
Equilin sodium sulfate
Equilin, sulfate, sodium salt (6CI)
Equin
ESE (Esterified Estrogen)
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt
Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-, hydrogen sulfate sodium salt (8CI)
Estra-1,3,5(10),7-tetraen-17-one,3-(sulfooxy)-,sodium salt
Estratab
Estrifol
Estroate
Estrocon
Estrogenic substances, cojugated
Estrogens conjugated [USP]
Estrogens, Conjugated
Estrogens, conjugated [USP:JAN]
Estrogens, conjugates
Estromed
Estropan
FEM H
Femacoid
Femavit
Femest
Formatrix
Ganeake
Genisis
Glyestrin
Hyphorin
J-004475
Kestrin
LS-2303
Mannest
Menogen
Menopak-E
Menoprem Continuous
Menotab
Menotrol
Menpoz
Msmed
Neo-Menovar
Novoconestron
Oestrilin
Oestro-feminal
Oestropak morning
Ovest
Palopause
PL043155
Premaril
Premaril Plus
PREMARIN (EQUILIN)
Premarin Crema V
Premarin Creme
Premarin Vaginal Creme
Premarina
Premarose
Prempak
Presomen
Prevagin-Premaril
Primarin
Promarit
Provette Continuous
Romeda
SCHEMBL974791
Sefac
Sodestrin-H
SODIUM (1S,11S,15S)-15-METHYL-14-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5,9-TETRAEN-5-YL SULFATE
sodium 17-oxoestra-1(10),2,4,7-tetraen-3-yl sulfate
Sodium equilin 3-monosulfate
Sodium equilin sulfate
Sodium estrone sulfate, mixted with sodium equilin sulfate
Srogen
Sukingpo
TAG-39
Theogen
Transannon
UNII-3ASP8Q3768 component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-7XY8FW3E68
UNII-8L6LAK9BTR component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-IU5QR144QX component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-JM2621P2LS component QTTMOCOWZLSYSV-QWAPEVOJSA-M
Zeste

US Patents and Regulatory Information for PREMARIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc PREMARIN estrogens, conjugated CREAM;TOPICAL, VAGINAL 020216-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-006 Jul 16, 2003 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PREMARIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated TABLET;ORAL 004782-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PREMARIN estrogens, conjugated CREAM;TOPICAL, VAGINAL 020216-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Fish and Richardson
Accenture
Cerilliant
Julphar
Harvard Business School
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.